Obesity Archives

News and Trends 11 Apr 2017

French Microbiome Startup Gets a Series A Funding Boost to Regulate Appetite

The French biotech startup TargEDys has extended its series A funding initiated in April 2016 by €3.5M to accelerate the development of its pipeline. After raising an initial €5.8M in a series A funding round from big names like Seventure Partners, TargEDys has now raked an additional €3.5M from the Zaluvida group. The company has also appointed Christoph […]

April 11, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 12 Jan 2017

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

Novartis is initiating Phase II trials with an antibody licensed from German biotech MorphoSys that tackles the obesity and diabetes epidemic. MorphoSys is a billion euro biotech that develops therapeutic antibodies for big names like Bayer, Pfizer, GSK, Boehringer Ingelheim, Roche and Janssen. The company is now adding type 2 diabetes to its long list of indications; bimagrumab will start Phase […]

January 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Jan 2017

Top European VC and CRO fund Young Metabolic Disease Biotech

Eternygen has received €8M in a Series A round led by Epidarex Capital that will be used to advance its pipeline in collaboration with Evotec. Eternygen is a young biotech in Berlin focusing on the treatment of metabolic diseases. The company has now raised €8M in Series A, led by Scottish biotech VC Epidarex Capital. Among the […]

January 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

obesity microbiome research kings college

News and Trends 5 Oct 2016

New Link found between the Microbiome and “Genetic Obesity”

Researchers at King’s College London have found a new link between gut microbiome diversity (or, more specifically, the lack of it) and a particularly troubling kind of obesity. This finding could also help explain the inheritability of this disease. The explosive growth of the Microbiome field promises a whole new type of therapies, but this […]

October 5, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 26 Nov 2015

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

Ablynx – the Belgian Nanobody biotech (which uses monoclonal antibodies of Alpacas) has entered a new and exclusive partnership with the Danish Novo Nordisk on a mysterious disease… Ablynx are famously well connected in the biotech industry, with many huge pharmas licensing out their Alpaca-nanobody tech. Partnerships include AbbVie (Immunology), Boehringer Ingelheim, Genzyme (Multiple Sclerosis/CNS), […]

November 26, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 17 May 2015

The Miracle Berry which Hacks your Taste Buds to Replace Sugar

Can you name a fruit capable of disturbing your taste buds? For up to two hours, the red miracle berry can transform sour foods like lemon or vinegar, in an amazing sweet taste. It’s a very interesting berry because of its non-caloric property for anti-obesity and anti-diabetes use. This miracle berry that grows in West Africa contains Miraculin, […]

May 17, 2015 - 3 minutesmins - By Julie Lellouche

News and Trends 24 Apr 2015

Novo Nordisk Takes on One of the World’s Biggest Markets: Obesity

Novo Nordisk, the Danish global healthcare company, received the all clear a few month ago from the US, EU and Canada to launch and sell a new treatment for Weight Management, Saxenda. The company announced the launch of Saxenda in the US, who present the treatment as an adjunct to a reduced-calorie diet and increased physical activity for chronic […]

April 24, 2015 - 2 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Obesity

French Microbiome Startup Gets a Series A Funding Boost to Regulate Appetite

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

Top European VC and CRO fund Young Metabolic Disease Biotech

New Link found between the Microbiome and “Genetic Obesity”

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

The Miracle Berry which Hacks your Taste Buds to Replace Sugar

Novo Nordisk Takes on One of the World’s Biggest Markets: Obesity

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!